Home >> Signaling Pathways >> Neuroscience >> Amyloid β

Amyloid β

Amyloid β denotes peptides of 36–43 amino acids result from the APP (amyloid precursor protein) and are involved in Alzheimer's disease as the main component of the amyloid plaques.

Products for  Amyloid β

  1. Cat.No. Product Name Information
  2. GC63273 β-Amyloid (1-14),mouse,rat β-Amyloid (1-14),mouse,rat  Chemical Structure
  3. GC63274 β-Amyloid (1-42), (rat/mouse) (TFA) β-Amyloid (1-42), (rat/mouse) (TFA)  Chemical Structure
  4. GC37984 β-Amyloid (1-42), rat β-Amyloid (1-42), rat  Chemical Structure
  5. GC61394 β-Amyloid (1-42), rat TFA β-Amyloid (1-42), rat TFA  Chemical Structure
  6. GC37991 β-Amyloid 15-21 β-Amyloid 15-21  Chemical Structure
  7. GC34242 β-Amyloid (1-42), rat TFA β-Amyloid (1-42), rat TFA  Chemical Structure
  8. GC31146 β-Amyloid (10-35), amide β-Amyloid (10-35), amide  Chemical Structure
  9. GC31129 β-Amyloid 1-16 (Amyloid β-Protein (1-16)) β-Amyloid 1-16 (Amyloid β-Protein (1-16))  Chemical Structure
  10. GC31171 β-Amyloid 1-28 (Amyloid β-Protein (1-28)) β-Amyloid 1-28 (Amyloid β-Protein (1-28))  Chemical Structure
  11. GC30325 β-Amyloid 22-35 (Amyloid β-Protein (22-35)) β-Amyloid 22-35 (Amyloid β-Protein (22-35))  Chemical Structure
  12. GC31137 β-Amyloid 29-40 (Amyloid beta-protein(29-40)) β-Amyloid 29-40 (Amyloid beta-protein(29-40))  Chemical Structure
  13. GC31179 β-Amyloid 31-35 β-Amyloid 31-35  Chemical Structure
  14. GC16032 (R,S)-Anatabine Aβ inhibitor (R,S)-Anatabine  Chemical Structure
  15. GC16139 (R,S)-Anatabine (tartrate) Aβ inhibitor (R,S)-Anatabine (tartrate)  Chemical Structure
  16. GC30952 4-(6-Bromo-2-benzothiazolyl)-N-methylbenzenamine 4-(6-Bromo-2-benzothiazolyl)-N-methylbenzenamine  Chemical Structure
  17. GC31208 4-(6-Bromo-2-benzothiazolyl)benzenamine 4-(6-Bromo-2-benzothiazolyl)benzenamine  Chemical Structure
  18. GC63502 Aβ/tau aggregation-IN-1 Aβ/tau aggregation-IN-1  Chemical Structure
  19. GC31259 Aftin-4 Aftin-4  Chemical Structure
  20. GC65281 Aleplasinin Aleplasinin  Chemical Structure
  21. GC62834 ALZ-801 ALZ-801  Chemical Structure
  22. GC35334 Amyloid β Peptide (42-1)(human) Amyloid β Peptide (42-1)(human)  Chemical Structure
  23. GA20735 Amyloid β-Protein (1-42) For a detailed description of Aβ 1-42, please see product H-1368. For the preparation of Aβ for experimental use, Fezoui et al. (2000) found that solvation of synthetic peptide with sodium hydroxide (Aβ.NaOH) followed by lyophilization, produced stocks with superior solubility and fibrillogenesis characteristics. Solubilization of the pretreated material with neutral buffers resulted in a pH transition from ≈10.5 to neutral, avoiding the isoelectric point of Aβ (pI≈5.5), at which Aβ precipitation and aggregation propensity are maximal. Amyloid β-Protein (1-42)  Chemical Structure
  24. GA20734 Amyloid β-Protein (1-42) Amyloid β-Protein (1-42)  Chemical Structure
  25. GA20733 Amyloid β-Protein (1-42)

    Compared to the inner salt, the HCl salt of Aβ42 aggregates more readily at pH 7.4.

    Amyloid β-Protein (1-42)  Chemical Structure
  26. GA20732 Amyloid β-Protein (1-42) Aβ 1-42, 42-residue fragment of amyloid precursor protein, has been found to be a major constituent of the senile plaques formed in the brains of patients with Alzheimer's disease and late Down's syndrome. Aβ 1-42 readily forms neurotoxic oligomers at physiological pH. On the other hand, the peptide shows antimicrobial activity. The sequence of H-1368 corresponds to the human, bovine, canine, feline, ovine, guinea pig, and rabbit Aβ42 peptide. The peptide has been used to detect amyloid β-protein multimers in the cerebrospinal fluid of Alzheimer's disease patients through fluorescence correlation spectroscopy. For detailed descriptions of the preparation of Aβ 1-42 monomers and protofibrils please see the papers of Jan, Hartley, and Lashuel, Stine et al. (2011), and of Broersen and colleagues. The findings of Ryan et al. indicate that 10% ammonia disaggregates Aβ42 more efficiently than HFIP. Amyloid β-Protein (1-42)  Chemical Structure
  27. GA20730 Amyloid β-Protein (1-42) (HFIP-treated) H-7442 was obtained by dissolving Amyloid β-Protein (1-42) (H-1368) in HFIP, aliquoting, and removing the solvent as described in the literature. Amyloid β-Protein (1-42) (HFIP-treated)  Chemical Structure
  28. GA20736 Amyloid β-Protein (1-43) The amyloid β-protein is a 39- to 43-amino acid polypeptide that is the primary constituent of senile plaques and cerebrovascular deposits in Alzheimer's disease and Down's syndrome. Additionally it acts as an inhibitor of the ubiquitin-dependent protein degradation in vitro. Amyloid β-Protein (1-43)  Chemical Structure
  29. GP10099 amyloid A protein fragment [Homo sapiens] Apolipoproteins related to HDL in plasma amyloid A protein fragment [Homo sapiens]  Chemical Structure
  30. GP10118 Amyloid Beta-Peptide (1-40) (human) Amyloid precursor protein Amyloid Beta-Peptide (1-40) (human)  Chemical Structure
  31. GP10049 Amyloid Beta-Peptide (12-28) (human)


    Amyloid Beta-Peptide (12-28) (human)  Chemical Structure
  32. GP10082 Amyloid Beta-peptide (25-35) (human)

    Functional domain of Aβ

    Amyloid Beta-peptide (25-35) (human)  Chemical Structure
  33. GC33160 amyloid P-IN-1 amyloid P-IN-1  Chemical Structure
  34. GP10046 Amyloid Precursor C-Terminal Peptide

    For beta amyloid generation

    Amyloid Precursor C-Terminal Peptide  Chemical Structure
  35. GP10057 Amyloid β-Peptide (10-20) (human)

    Initiates neurodegeneration in Alzheimer disease

    Amyloid β-Peptide (10-20) (human)  Chemical Structure
  36. GP10094 Amyloid β-peptide (10-35), amide Truncated peptide model Amyloid β-peptide (10-35), amide  Chemical Structure
  37. GP10097 Amyloid β-Protein (1-15)

    Principal component of amyloid

    Amyloid β-Protein (1-15)  Chemical Structure
  38. GC39254 Anatabine dicitrate Anatabine dicitrate  Chemical Structure
  39. GC11309 ARN2966

    APP expression modulator

    ARN2966  Chemical Structure
  40. GC19053 Azeliragon TTP488 is an antagonist at the Receptor for Advanced Glycation End products, is evaluated as a potential treatment for patients with mild-to-moderate Alzheimer's disease (AD). Azeliragon  Chemical Structure
  41. GP10083 Beta-Amyloid (1-11) Amyloidogenic peptide Beta-Amyloid (1-11)  Chemical Structure
  42. GC34232 Beta-Amyloid(1-14),mouse,rat Beta-Amyloid(1-14),mouse,rat  Chemical Structure
  43. GC31124 BF 227 BF 227  Chemical Structure
  44. GC33750 BF-168 BF-168  Chemical Structure
  45. GC15950 CGP 52411 EGFR inhibitor CGP 52411  Chemical Structure
  46. GC61887 Cl-NQTrp Cl-NQTrp  Chemical Structure
  47. GC14854 Colivelin Neuroprotective peptide and activator of STAT3 Colivelin  Chemical Structure
  48. GC35720 Colivelin TFA Colivelin TFA  Chemical Structure
  49. GC14828 CPHPC used with anti-SAP antibodies to eliminate amyloid deposits CPHPC  Chemical Structure
  50. GC10230 CRANAD 2 near-infrared probe that binds to Aβ40 aggregates CRANAD 2  Chemical Structure
  51. GC12942 DAPT (GSI-IX)

    DAPT (GSI-IX) is an orally active γ-secretase inhibitor with IC50s of 115 nM and 200 nM for total amyloid-β (Aβ) and Aβ42 produced in human primary neuronal cultures, respectively.

    DAPT (GSI-IX)  Chemical Structure
  52. GC50733 Davunetide Davunetide  Chemical Structure
  53. GC13554 Deferoxamine mesylate

    Deferoxamine mesylate is a drug that chelates iron by forming a stable complex that prevents the iron from entering into further chemical reactions, and is used for the treatment of chronic iron overload in patients with transfusion-dependent anemias.

    Deferoxamine mesylate  Chemical Structure
  54. GC13256 Dihydroergocristine mesylate 5-HT receptor antagonist and partial agonist of adrenergic and dopaminergic receptors Dihydroergocristine mesylate  Chemical Structure
  55. GC31083 DWK-1339 (MDR-1339) DWK-1339 (MDR-1339)  Chemical Structure
  56. GC30823 Edonerpic maleate (T-817 maleate) Edonerpic maleate (T-817 maleate)  Chemical Structure
  57. GC10660 EHT 1864 Rac family small GTPases inhibitor EHT 1864  Chemical Structure
  58. GC10089 EUK 134 Salen-manganese complexes;SOD mimetic EUK 134  Chemical Structure
  59. GC62966 Ezeprogind disulfate Ezeprogind disulfate  Chemical Structure
  60. GC61476 Fmoc-Ala-Glu-Asn-Lys-NH2 Fmoc-Ala-Glu-Asn-Lys-NH2  Chemical Structure
  61. GC15105 FPS-ZM1 A RAGE Inhibitor FPS-ZM1  Chemical Structure
  62. GC36076 Frentizole Frentizole  Chemical Structure
  63. GC36110 gamma-Secretase Modulators gamma-Secretase Modulators  Chemical Structure
  64. GN10428 Geniposide Iridoid glycoside with various bioactivities Geniposide  Chemical Structure
  65. GN10307 Ginsenoside Re Ginsenoside Re may have properties that inhibit or prevent the growth of tumors. Ginsenoside Re  Chemical Structure
  66. GN10544 Ginsenoside Rg1 Triterpene saponins/steroid glycosides found in Panax Ginsenoside Rg1  Chemical Structure
  67. GN10614 Ginsenoside Rg2 Ginsenoside Rg2 may have properties that inhibit or prevent the growth of tumors. Ginsenoside Rg2  Chemical Structure
  68. GN10799 Ginsenoside Rg3 Ginsenoside Rg3 affects endothelium dependent relaxation in the aorta. Ginsenoside Rg3  Chemical Structure
  69. GC30892 Glutaminyl Cyclase Inhibitor 1 Glutaminyl Cyclase Inhibitor 1  Chemical Structure
  70. GC31110 Glutaminyl Cyclase Inhibitor 2 Glutaminyl Cyclase Inhibitor 2  Chemical Structure
  71. GC17657 Hoechst 34580 Blue fluorescent dyes Hoechst 34580  Chemical Structure
  72. GC36247 Hoechst 34580 tetrahydrochloride Hoechst 34580 tetrahydrochloride  Chemical Structure
  73. GC10988 J 147 reduces soluble Aβ40 and Aβ42 levels J 147  Chemical Structure
  74. GC30920 K 01-162 (K162) K 01-162 (K162)  Chemical Structure
  75. GC17974 Latrepirdine Brain cell death inhibitor Latrepirdine  Chemical Structure
  76. GC38628 Licochalcone B Licochalcone B  Chemical Structure
  77. GC12366 LPYFD-NH2 neuroprotective peptide that binds to amyloid beta (Aβ) LPYFD-NH2  Chemical Structure
  78. GC30884 LX2343 LX2343  Chemical Structure
  79. GC10894 Methoxy-X04

    Fluorescent amyloid β (Aβ) probe

    Methoxy-X04  Chemical Structure
  80. GC31285 MK-3328 MK-3328  Chemical Structure
  81. GN10695 Notoginsenoside R1 Notoginsenoside R1 has been shown to exhibit antooxidant,anti-inflammatory,antiapoptotic,and immune-stimulatory properties. Notoginsenoside R1  Chemical Structure
  82. GC17037 NQTrp inhibitor of Alzheimer’s disease-associated amyloid β (Aβ) oligomerization and fibrillization NQTrp  Chemical Structure
  83. GC13783 Phenserine acetylcholinesterase inhibitor Phenserine  Chemical Structure
  84. GC62702 RAGE antagonist peptide TFA RAGE antagonist peptide TFA  Chemical Structure
  85. GC10425 Ro 90-7501

    Inhibitor of amyloid β42 (Aβ42) fibril assembly

    Ro 90-7501  Chemical Structure
  86. GC44856 Rutin (hydrate) Rutin is a natural flavonol glycoside with iron chelating and antioxidant properties. Rutin (hydrate)  Chemical Structure
  87. GN10502 Saikosaponin C Reported to induce cell growth and migration Saikosaponin C  Chemical Structure
  88. GN10313 Schisantherin B Extracted from Schisandra chinensis (Turcz.)Baill. seeds and stems;Store the product in sealed, cool and dry condition Schisantherin B  Chemical Structure
  89. GC37610 Scyllo-Inositol Scyllo-Inositol  Chemical Structure
  90. GC12096 Semagacestat (LY450139)

    γ-secretase inhibitor

    Semagacestat (LY450139)  Chemical Structure
  91. GC37639 Silybin B Silybin B  Chemical Structure
  92. GC17007 TAE-1 inhibitor of amyloid-β fibril formation and aggregation TAE-1  Chemical Structure
  93. GC64934 Thiethylperazine Thiethylperazine  Chemical Structure
  94. GC64935 Thiethylperazine dimaleate Thiethylperazine dimaleate  Chemical Structure
  95. GC63230 TML-6 TML-6  Chemical Structure
  96. GC17921 Tolcapone

    COMT inhibitor

    Tolcapone  Chemical Structure
  97. GC17910 Tramiprosate maintains Aβ in a non-fibrillar form. Tramiprosate  Chemical Structure
  98. GC65582 Tramiprosate-d6 Tramiprosate-d6  Chemical Structure
  99. GC16243 β-Amyloid (1-42), human TFA β-Amyloid (1-42), human TFA  Chemical Structure

98 Item(s)

per page

Set Descending Direction